Showing results (451-460 of 5,696) with videos related to
Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|March 14, 2014
Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathwayXiaoyu Wu, Yun Chen, Gang Li, et al.Medical Oncology (Northwood, London, England)|March 25, 2014
MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphomaWan-ling Wang, Cui Yang, Xiao-lin Han, et al.Medical Oncology (Northwood, London, England)|March 25, 2014
Serum omentin level in patients with prostate cancerUgur Uyeturk, Hasmet Sarıcı, Buket Kın Tekce, et al.Medical Oncology (Northwood, London, England)|October 10, 2009
VEGF -460C>T polymorphism and cancer risk: a meta-analysisBin Xu, Ning-Han Feng, Na Tong, et al.Medical Oncology (Northwood, London, England)|February 19, 2014
Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution seriesIcro Meattini, Sara Cecchini, Cristina Muntoni, et al.Medical Oncology (Northwood, London, England)|February 1, 2017
Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancerMarise R Heerma van Voss, Justin D Brilliant, Farhad Vesuna, et al.Medical Oncology (Northwood, London, England)|January 12, 2017
KRAS, NRAS and BRAF mutations in colorectal cancer and melanomaJonas Cicenas, Linas Tamosaitis, Kotryna Kvederaviciute, et al.Medical Oncology (Northwood, London, England)|January 13, 2017
Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancerTengyue Zeng, Libing Zhu, Min Liao, et al.Medical Oncology (Northwood, London, England)|January 13, 2017
Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxelJessica Ley, Tanya M Wildes, Kristin Daly, et al.Medical Oncology (Northwood, London, England)|March 3, 2019
Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancerYuichi Ozawa, Yusuke Amano, Kei Kanata, et al.Pageof 570